A quarter of our very elderly have undiagnosed treatable heart problems, research reveals
2012-07-25
(Press-News.org) The very oldest in our society are missing out on simple heart treatments which can prolong and improve their quality of life, Newcastle heart experts say.
Studying a group of people aged 87 to 89 years old, the team of researchers at Newcastle University found that a routine test in the home revealed that around a quarter of them had undiagnosed heart problems which could be treated with established and cost-effective treatments.
In the study, funded by the British Heart Foundation (BHF), the team visited the homes of 376 people aged 87 to 89 years old and carried out echocardiograms -heart scans- using portable instruments.
Publishing today in Heart, they reveal that around a quarter (26%) of the people involved had a previously undiagnosed heart problem, in particular, impairment of left ventricular systolic function. Affected people's hearts do not contract strongly enough, which can leave them breathless and lead to heart failure. The condition is treatable with established drugs such as beta-blockers and ACE inhibitors.
BHF Professor Bernard Keavney, a cardiologist at Newcastle University who led the study, admits to being taken aback at the extent of the problem: "We were surprised to discover just how many older people have heart problems. Many of these people could be treated with drugs that we know work, if their condition were recognised.
"Our research suggests that it might be practical to offer people over 85 who are breathless, an echocardiogram at home which would reveal these problems. Because this heart problem occurs so often at this age, home checks are likely to be cost-effective, whereas they wouldn't be in younger people In those people found to have hearts that were not pumping strongly enough on a home scan, medication could be considered. This would improve their quality of life and it's likely to slow their progression to heart failure.
"With heart failure, prevention is definitely a priority. Older patients coming into hospital with worsening heart failure is one of the largest sources of expenditure for the NHS. The number of people over 85 is already soaring, and this will continue for the foreseeable future. So anything we can do to improve the heart health of our oldest old is likely to have a big impact."
Taking part in the research were people involved in the Newcastle 85+ study, a unique study of the health of more than one thousand people from Newcastle and North Tyneside born in 1921.
"This is a group of people who are routinely excluded from trials of treatment on the grounds of their age," adds Dr. Joanna Collerton, Senior Clinical Research Associate at Newcastle's Institute for Ageing and Health and the study's co-lead author. "What we have discovered is that very many more people in this age group have heart problems compared to those in younger age groups so we need to think about more inclusive trials or trials focusing exclusively on older groups to ensure that as we face a growing older population we offer them the healthiest future."
Dr Shannon Amoils, Research Advisor at the BHF, said: "This study suggests that there are probably many more very elderly people in the community with heart problems than we previously supposed and many have symptoms like breathlessness that limits their daily activities. Despite this, their heart condition is often not recognised."
This research builds on Newcastle University's work as part of the Newcastle Initiative on Changing Age and the Newcastle institute for Social Renewal. This the University's response to the societal challenges including ageing, seeking new ways to make the most of the extensive opportunities associated with increasing human longevity, while at the same time solving some of the problems.
INFORMATION:
The Newcastle 85+ Study is funded principally by the Medical Research Council and Dunhill Medical Trust.
Reference: Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study. Heart
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-07-25
The truth behind some of the world's most famous historical myths, including Homer's epic, the Iliad, has been bolstered by two researchers who have analysed the relationships between the myths' characters and compared them to real-life social networks.
In a study published online today, 25 July, in the journal EPL (Europhysics Letters), Pádraig Mac Carron and Ralph Kenna from Coventry University performed detailed text analyses of the Iliad, the English poem, Beowulf, and the Irish epic, the Táin Bó Cuailnge.
They found that the interactions between the characters ...
2012-07-25
Programmed cell death (PCD) is a highly regulated process that occurs in all animals and plants as part of normal development and in response to the environment. New research published in BioMed Central's open access journal BMC Plant Biology is the first to document the physiological events in the lace plant (Aponogeton madagascariensis) which occur via PCD to produce the characteristic holes in its leaves.
The aquatic lace plant, endemic to Madagascar, uses PCD to generate holes in its leaves. Researchers from Dalhousie University, Nova Scotia, used long-term live ...
2012-07-25
Of 63,942 new cases of cutaneous melanoma (a form of skin cancer) diagnosed each year in Europe an estimated 3,438 (5.4%) are related to sunbed use. Sunbed users are at a 20% increased relative risk of skin cancer compared with those who have never used a sunbed. This risk doubles if they start before the age of 35 and experts warn that "tougher actions" are needed to reduce this risk.
Sun exposure is the most significant environmental cause of skin cancer and sunbeds have become the main non-solar source of UV exposure in Western Europe (UV is the wavelength associated ...
2012-07-25
Research: Use of risk assessment instruments to predict violence and antisocial behaviour in 73 samples involving 24,827 people: systematic review and meta-analysis
Tools designed to predict an individual's risk of repeat offending are not sufficient on their own to inform sentencing and release or discharge decisions, concludes a study published on bmj.com today.
Although they appear to identify low risk individuals with high levels of accuracy, the authors say "their use as sole determinants of detention, sentencing, and release is not supported by the current evidence."
Risk ...
2012-07-25
Research: Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study
Substantial overdiagnosis and mistreatment of malaria is evident in south and central Asia, warns a study published on bmj.com today.
With more than two billion people at risk of malaria in this part of Asia – larger than that of Africa - this is a major public health problem which needs to be confronted, say the authors.
Malaria remains one of the most important infectious diseases of poverty. Recent global malaria treatment ...
2012-07-25
CHICAGO --- A new class of drug developed at Northwestern University Feinberg School of Medicine shows early promise of being a one-size-fits-all therapy for Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain.
Northwestern has recently been issued patents to cover this new drug class and has licensed the commercial development to a biotech company that has recently completed the first human Phase 1 clinical trial for the drug.
The drugs in this class target a particular type of brain inflammation, ...
2012-07-25
BOSTON (July 24, 2012, 5:00PM EST)—A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer's disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer's. The paper, published in The Journal of Neuroscience, identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results may lead to the development of a drug treatment that targets this mechanism to slow ...
2012-07-25
LEXINGTON, Ky. (July 25, 2012) — In a study published June 25 in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer's pathology in a mouse model of the disease. The drug, called MW-151, is a selective suppressor of brain inflammation and overproduction of proinflammatory molecules from glial ...
2012-07-25
Alexandria, VA – December 21, 2012 – the purported last day of a 5,125-year cycle in the Mesoamerican calendar – has been added to an endless list of days when the world has been expected to end. But what are our real chances of being wiped out by a catastrophic event – the kind that has happened in the past and will inevitably occur again someday? In the August issue of EARTH, we explore four of the most probable global events that could change life on Earth forever.
Near-Earth objects (NEOs), super-eruptions, solar storms and cataclysmic earthquakes all pose serious ...
2012-07-25
University of Michigan heart researchers are shedding light on a safer method for steadying an abnormal heart rhythm that prevents collateral damage to healthy cells.
Irregular heart rhythms, or arrhythmias, set the stage for a common, debilitating disorder called atrial fibrillation that puts adults as young as age 40 at risk for fatigue, fainting, cardiac arrest, and even death. Medications can help, but doctors also use catheter ablation in which electrical impulses are delivered to a region of the heart to disrupt the arrhythmia.
However, studies show half of patients ...
LAST 30 PRESS RELEASES:
[Press-News.org] A quarter of our very elderly have undiagnosed treatable heart problems, research reveals
